ArticleEMBO molecular medicine2019

Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy.

Miren Zuazo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.